Andrew Lam
InvestorManaging Director, Head of Biotech Private Equity at Ally Bridge Group
Find your path to Andrew
8 people in our graph share verified history with Andrew — schools, employers, funds. One of them is your warm intro.
Eric KwongunlockedAndrew: together at Ally Bridge Group
×7Andrew: together at Ally Bridge Group
About
Managing Director and Head of Biotech Private Equity at Ally Bridge Group who led the firm's investment in Epicrispr and joined its board of directors.
Colleagues at Ally Bridge Group
Carlos Solórzano
Principal at S32
Frank Yu
Investor at Ally Bridge Group
Kevin Reilly
Managing Director and Head of MedTech Investments at Ally Bridge Group
Megan MacDonagh
Senior Associate at SV Health Investors
Slanix Paul Alex
President and Portfolio Manager, Public Equity at Ally Bridge Group
Steven Plachtyna
Investor at Ally Bridge Group
Frequently asked questions
- Who is Andrew Lam?
- Managing Director and Head of Biotech Private Equity at Ally Bridge Group who led the firm's investment in Epicrispr and joined its board of directors.
- Where does Andrew Lam work?
- Andrew Lam is Managing Director, Head of Biotech Private Equity at Ally Bridge Group.